Showing results (401-410 of 502) with videos related to

Sort By:
Pageof 51
Circulation. Cardiovascular Interventions|March 18, 2026
Clopidogrel Versus Aspirin Monotherapy Beyond 1 Year After PCI: The Final 5-Year Results of the STOPDAPT-2 ACS and STOPDAPT-2 Total CohortHirotoshi Watanabe, Takeshi Morimoto, Masahiro Natsuaki, et al.
Circulation. Cardiovascular Interventions|May 18, 2021
Very Short Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation in Patients Who Underwent Complex Percutaneous Coronary Intervention: Insight From the STOPDAPT-2 TrialKo Yamamoto, Hirotoshi Watanabe, Takeshi Morimoto, et al.
JACC. Heart Failure|March 15, 2025
Validation of Guideline Recommendation on Sudden Cardiac Death Prevention in Hypertrophic CardiomyopathyMasashi Amano, Hiroaki Kitaoka, Yusuke Yoshikawa, et al.
ESC Heart Failure|October 14, 2022
A comparison between hospital follow-up and collaborative follow-up in patients with acute heart failureKoichi Washida, Takao Kato, Neiko Ozasa, et al.
ESC Heart Failure|August 30, 2023
The characteristics and outcomes in patients with acute heart failure who used tolvaptan: from KCHF registryRyusuke Nishikawa, Takao Kato, Takeshi Morimoto, et al.
European Heart Journal|May 17, 2022
Duration of antiplatelet therapy after complex percutaneous coronary intervention in patients at high bleeding risk: a MASTER DAPT trial sub-analysisMarco Valgimigli, Pieter C Smits, Enrico Frigoli, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|September 3, 2021
Clinical outcomes according to lesion complexity in high bleeding risk patients treated with 1-month dual antiplatelet therapy following PCI: Analysis from the Onyx ONE clear studyDavid E Kandzari, Ajay J Kirtane, Roxana Mehran, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|April 28, 2021
Effects of Acute Coronary Syndrome and Stable Coronary Artery Disease on Bleeding and Ischemic Risk After Percutaneous Coronary InterventionMasahiro Natsuaki, Takeshi Morimoto, Hiroki Shiomi, et al.
Journal of Cardiology|February 5, 2025
Polymer-free sirolimus- and probucol-eluting stents versus durable polymer-based everolimus-eluting stents for percutaneous coronary revascularization: A prospective multicenter randomized clinical trialAkihiro Ikuta, Junji Yajima, Shinya Okazaki, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|March 18, 2025
Cutting balloon versus standard balloon for lesion preparation of drug-coated balloon treatment in de-novo coronary artery lesions: Rationale and Design of the Randomized NATURE trialMasafumi Ono, Taku Asano, Masahiko Noguchi, et al.
Pageof 51